Registry on controlling blood pressure in ten thousand patients
A Registry Study on the "Action of Controlling Ambulatory Blood Pressure to Target in Ten Thousand Patients"
This study is testing how well 24-hour blood pressure monitoring can help people with high blood pressure manage their condition and improve their heart health.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Shanghai Institute of Hypertension Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Trial ID | NCT03547856 on ClinicalTrials.gov |
What this trial studies
This observational study aims to register information on hypertensive patients using 24-hour ambulatory blood pressure (ABP) monitoring across China. It seeks to evaluate the effectiveness of ABP monitoring in managing hypertension and its impact on cardiovascular outcomes. The study highlights the importance of accurate blood pressure measurement in daily life to identify various forms of hypertension that traditional methods may miss. By promoting the clinical application of ABP monitoring, the study aims to improve hypertension management and reduce associated health risks.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18-80 with clinically diagnosed hypertension who are currently using antihypertensive medications.
Not a fit: Patients who are not on antihypertensive drugs or those who are hospitalized for hypertension may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management of hypertension and a reduction in cardiovascular events among patients.
How similar studies have performed: Previous studies have shown success with ambulatory blood pressure monitoring, indicating its potential effectiveness in managing hypertension.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18-80 years old * Clinical diagnosed hypertension with the use of antihypertensive drugs * A 24-hour ambulatory blood pressure monitoring was performed with validated equipment. * Willing to provide information about disease history and blood biochemical test data within 6 months. * Sign the informed consent Exclusion Criteria: * Without antihypertensive drug use * Hospitalized hypertension patients * Non-compliant patient
Where this trial is running
Shanghai, Shanghai Municipality
- Ruijin Hospital — Shanghai, Shanghai Municipality, China (Recruiting)
Study contacts
- Principal investigator: Yan Li — Shanghai Institute of Hypertension
- Study coordinator: Yan Li, Professor
- Email: liyanshcn@yahoo.com
- Phone: 021-64370045
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.